ALLERO THERAPEUTICS
Allero Therapeutics is a biopharmaceutical company that develops next generation immunotherapies for immune mediated disorders. Based on research by the founders and their collaborators the team has identified a novel specific immunotherapy approach based on antigen-specific tolerance induction. The approach defines a platform technology which is broadly applicable to a range of clinical indications with profound unmet medical need.
ALLERO THERAPEUTICS
Social Links:
Industry:
Biotechnology Pharmaceutical
Founded:
2016-01-01
Address:
Rotterdam, Zuid-Holland, The Netherlands
Country:
The Netherlands
Website Url:
http://www.allerotherapeutics.com
Total Employee:
101+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
2.57 M EUR
Technology used in webpage:
Euro Google Google Cloud Wix
Similar Organizations
Accent Therapeutics
Accent Therapeutics is a biopharmaceutical company.
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
IntraBio
IntraBio is a biopharmaceutical company.
Nymox Pharmaceutical
Nymox Pharmaceutical is a biopharmaceutical company.
Relevium Medical
Relevium Medical is a biopharmaceutical company offering medicines for osteoarthritis.
Saol Therapeutics
Saol Therapeutics is a biotech pharmaceutical company.
Swedish Orphan Biovitrum
International Pharmaceutical Manufacture
Zentera Therapeutics
Zentera Therapeutics is a biopharmaceutical company.
Current Employees Featured
Founder
Investors List
European Innovation Council
European Innovation Council investment in Grant - Allero Therapeutics
Swanbridge Capital
Swanbridge Capital investment in Seed Round - Allero Therapeutics
EASME - EU Executive Agency for SMEs
EASME - EU Executive Agency for SMEs investment in Grant - Allero Therapeutics
Official Site Inspections
http://www.allerotherapeutics.com
- Host name: unalocated.63.wixsite.com
- IP address: 185.230.63.171
- Location: Ashburn United States
- Latitude: 39.018
- Longitude: -77.539
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20147
More informations about "Allero Therapeutics"
About - Allero Therapeutics
Allero has received funding from the European Union’s Horizon 2020 research and innovation programme (SME Instrument Phase 1) under grant no 827234 and the EIC Accelerator programme (SME Intrument Phase 2) under grant no …See details»
Allero Therapeutics - Crunchbase Company Profile
Contact Email [email protected] Allero Therapeutics is a biopharmaceutical company that develops next generation immunotherapies …See details»
Allero Therapeutics BV - Drug pipelines, Patents, Clinical trials
Www.allerotherapeutics.com. Startups | Holding Company | 2016 | Netherlands | 100-250 | www.allerotherapeutics.com. Last update 01 Nov 2024. Overview. Pipeline. Deal. …See details»
Allero Therapeutics BV - LinkedIn
Allero Therapeutics is a Dutch biotech company that develops next generation immunotherapies for immune mediated disorders. Our goal is to develop novel targeted treatments that induce long ...See details»
TEAM - Allero Therapeutics
>25 years of Pharma/Biotech R&D experience in immunotherapy. Senior Management at ALK, Stallergenes, LEO Pharma, Micromet, Pharmacia. P rofessor of Biomedicine, PhD.See details»
Allero Therapeutics - PitchBook
Allero Therapeutics General Information Description. Developer of immunotherapies intended for immune-mediated disorders. The company offers non-invasive, patient-friendly treatments …See details»
Allero Therapeutics Overview | SignalHire Company Profile
Allero Therapeutics is a biopharmaceutical company that develops next generation immunotherapies for immune mediated disorders.\n\nBased on research by the founders and …See details»
Allero Therapeutics - Products, Competitors, Financials, Employees ...
Allero Therapeutics is a biotech company focused on developing next-generation immunotherapies for immune-mediated disorders. Use the CB Insights Platform to explore …See details»
ALLERO THERAPEUTICS - VentureRadar
Website: https://www.allerotherapeutics.com/ Develops next-generation immunotherapies for allergic and autoimmune diseases, focusing on food-related disorders using ...See details»
ALLERO THERAPEUTICS - VentureRadar
Website: https://www.allerotherapeutics.com/ Allero Therapeutics develops next generation immunotherapies for allergic and autoimmune disease patients, with a focus ...See details»
Allero Therapeutics - Company Profile - Tracxn
Nov 27, 2024 Allero Therapeutics - Developer of immunotherapies for allergy and autoimmune disease. Raised funding over 4 rounds from 4 investors. Founded by Emil Pot, Kees …See details»
Allero Therapeutics - Craft
Allero Therapeutics is a biopharmaceutical company that develops immunotherapies for allergic and autoimmune disease patients. Its proprietary SOMIT (Specific OroMucosal …See details»
Allero Therapeutics - Overview, News & Similar companies
Who is Allero Therapeutics. Allero Therapeutics was founded in November 2016 and seed-financed in 2019 by Curie Capital and Swanbridge Capital. Allero Therapeutics is an immun …See details»
Allero Therapeutics Company Information - Funding, Investors, …
Get information on funding, investors, industries, and more for Allero Therapeutics. See Allero Therapeutics company profile and funding data.See details»
☑️Allero Therapeutics — Consulting Organization from the …
Oct 11, 2024 Allero Therapeutics — Consulting Organization from the Netherlands, has experience with Horizon Europe (2021 - 2027), it`s involved in Health, Science & Innovation …See details»
Allero Therapeutics | EU-Startups
Articles about Allero Therapeutics: June 14, 2023 74 Top Biotechnology Startups and Companies in The Netherlands (2021); November 18, 2022 Weekly funding round-up! All of the European …See details»
Company News: Allero Therapeutics and Abbreos Join Forces to
Tuesday, 24. November 2020 Company News: Allero Therapeutics and Abbreos Join Forces to Clinically Develop COVID-19 Program. Allero Therapeutics BV, a Belgian-Dutch oromucosal …See details»
Allero: treating food-related immune diseases through an oral patch
May 17, 2021 Allero emerged from stealth last year to develop an oral patch-based immunotherapy that could lead to better compliance and fewer safety risks than other …See details»
NEWS - Allero Therapeutics
Dec 16, 2021 EIC + J&J Healthcare Investor Day Paris, 13 Nov 2024 . Aarhus Immunotherapy Symposium, 14 Nov 2024. Ag-specific Immune Tolerance Summit Boston, 25-27 Feb 2025See details»